Correlation Between Edgewise Therapeutics and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Seres Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Seres Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Seres Therapeutics
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Edgewise and Seres is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Seres Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Seres Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 3.04 times less risky than Seres Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Seres Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 76.00 in Seres Therapeutics on August 24, 2024 and sell it today you would lose (2.82) from holding Seres Therapeutics or give up 3.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Seres Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Seres Therapeutics |
Edgewise Therapeutics and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Seres Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Edgewise Therapeutics vs. ZyVersa Therapeutics | Edgewise Therapeutics vs. Sonnet Biotherapeutics Holdings | Edgewise Therapeutics vs. Zura Bio Limited | Edgewise Therapeutics vs. Phio Pharmaceuticals Corp |
| Seres Therapeutics vs. ZyVersa Therapeutics | Seres Therapeutics vs. Sonnet Biotherapeutics Holdings | Seres Therapeutics vs. Zura Bio Limited | Seres Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |